Announcements Trials
Browse Landscape

Phase

Phase 3 18Phase 2 17Phase 1/2 5Phase 1 4Phase 4 2Phase NA 1Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 44Radiosurgery 41Early Intervention, Educational 34Standard of Care 32Educational Status 31Exercise 30Methods 29Drug Therapy 26Radiotherapy 23Magnetic Resonance Spectroscopy 23Practice Guidelines as Topic 22Surveys and Questionnaires 21X-Rays 17Pemetrexed 17Carboplatin 16Biopsy 16Tomography, X-Ray Computed 14Thoracic Surgery, Video-Assisted 14Therapeutics 12Interviews as Topic 12Fluorodeoxyglucose F18 12Gefitinib 11Cisplatin 11Specimen Handling 10Patient Navigation 10Cryosurgery 10Anterior Temporal Lobectomy 10anlotinib 9Surgical Procedures, Operative 9Psychiatric Rehabilitation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Crizotinib × Thoracic × Clear all
NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡